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available evidence. The Editorial by Laakso and colleagues
has failed to advance the debate because it has not done
this. 
Chris Maher
The University of Sydney
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Continued research into electrophysical
agents is the way forward. (Reply to
Maher C, Australian Journal of
Physiotherapy 49: 65-66)
We thank Dr Maher for his interest in the Editorial in which
we argued for the continued inclusion of electrophysical
agents (EPAs) in the entry-level physiotherapy curricula
(Laakso et al 2002, Maher 2003). Our argument was
predicated on the existing evidence, clinical practices and
use of EPAs, and on safety issues. All aspects are integral
to our argument and to current discussions. 
The Editorial devoted considerable space to the problem of
obtaining adequate evidence. This included the decisions
about what constitutes quality evidence, and how evidence
is obtained and evaluated. Dr Maher’s letter argued that the
only way of “resolv(ing) this debate is to carefully consider
all the available evidence”. We agree and argued precisely
for this to precede decisions about EPAs in entry-level
curricula. However, we also discussed our concerns
regarding the current lack of high quality studies
investigating the clinical uses of EPAs and the problems in
relying on databases that depend on systematic reviews of
randomised controlled trials (RCTs), such as PEDro or the
Cochrane Library. We also discussed some inherent
problems in EPA research (eg dosage-related issues) and
the need to consider basic and applied research. Given the
extent of our discussion, we are puzzled as to why Dr
Maher is reporting Cochrane Library entries on some EPAs
and skin disorders, and think the choice somewhat
disingenuous. 
We welcome the opportunity of continuing this debate and
look forward to continued discussion of the relevant
aspects of the issue of EPAs in entry-level curricula. At this
stage though, we venture to repeat our suggestion of a way
forward: promote all types of research into EPAs. This is
also consistent with the need for a generally more
substantial evidence base for decision-making in
physiotherapy practice as a whole. And, if we then discuss
all the relevant evidence, not just reviews of RCTs, perhaps
we can then agree on which EPAs are clinically effective
and which are not. This may then assist educators in their
decisions as to what can and cannot justifiably be included
in future curricula.   
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